A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in Germany

德国医院管理视角下的贝洛妥珠单抗与仅使用标准抗生素治疗高危艰难梭菌感染复发患者的预算影响分析